نتایج جستجو برای: taraxastane prostate cancer cytotoxicity

تعداد نتایج: 965961  

Journal: :Cancer research 1995
G J Berchem M Bosseler L Y Sugars H J Voeller S Zeitlin E P Gelmann

We describe an in vitro model for prostate cancer treatment that suggests a potential benefit for combined androgen ablation and cytotoxic chemotherapy. Androgen treatment of the LNCaP hormone-dependent human prostate cancer cell line induces increased expression of the BCL-2 protein. Increased levels of this protein are known to mediate inhibition of apoptosis. LNCaP cells, however, did not un...

2017
Jorge Arroyo-Acevedo Oscar Herrera-Calderón Roberto Chávez-Asmat Andrea Anampa-Guzmán Víctor Chumpitaz-Cerrate Edwin Enciso-Roca

BACKGROUND The main objective was to evaluate the possible protective effect of Chuquiraga spinosa extract on N-methyl nitrosourea (NMU)-induced prostate cancer in rats and DU-145 cell line. MATERIALS AND METHODS Prostate carcinogenesis was induced in 30 male Holtzman rats by providing cyproterone acetate, testosterone, and NMU. The tumors were monitored and hematological and biochemical para...

Journal: :iranian journal of public health 0
farhad babaei 1. dept. of virology, school of public health, tehran university of medical sciences , tehran, iran. seyed ali ahmadi 2. school of medicine, tehran university of medical sciences , tehran, iran. ramin abiri 3. dept. of microbiology, school of medicine, kermanshah university of medical sciences , kermanshah, iran. farhad rezaei 1. dept. of virology, school of public health, tehran university of medical sciences , tehran, iran. maryam naseri 1. dept. of virology, school of public health, tehran university of medical sciences , tehran, iran. mahmoud mahmoudi 4. dept. of epidemiology and biostatistics, school of public health, tehran university of medical sciences , tehran, iran.

the tp53 gene is one of the most frequently mutated genes amongst human malignancies, particularly tp53 codon 72 polymorphism. furthermore, an association between the tp53 codon 72 variants and prostate cancer has been reported in several studies. although some studies have indicated an association between the tp53 arg/arg variant and an increased risk for prostate cancer, other studies have sh...

Journal: :European review for medical and pharmacological sciences 2014
Z-D Shi X-F Li L Hao Y Zhao Y-X Wang B-Z Dong W-H Chen Z-G Zhang Y-M Wang Q Fu C-H Han S Li

OBJECTIVE In recent years, the field of cancer immunotherapy has become a research hotspot and is currently faced with numerous challenges. The objective of this study was to assess the success of cbl-b gene silencing in splenic T lymphocytes as an immune strategy to target the murine prostate cancer RM-1 cells in vitro and solid tumors in vivo. MATERIALS AND METHODS For this purpose, cbl-b g...

Journal: :gene, cell and tissue 0
fernando augusto de lima marson department of medical genetics, faculty of medical sciences, state university of campinas (unicamp), campinas, são paulo, brazil; department of medical genetics, faculty of medical sciences, state university of campinas (unicamp), campinas, são paulo, brazil. tel: +55-1935218994/8902, fax: +55-1935219009 jose dirceu ribeiro department of pediatrics, faculty of medical sciences, state university of campinas (unicamp), campinas, são paulo, brazil carmen silvia bertuzzo department of medical genetics, faculty of medical sciences, state university of campinas (unicamp), campinas, são paulo, brazil

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1997
R Uslu N Borsellino P Frost H Gárban C P Ng Y Mizutani A Belldegrun B Bonavida

Androgen ablation has been an effective treatment in patients with advanced prostate cancer. However, most treated patients develop hormonally resistant disease and do not respond to conventional chemotherapy. Immunotherapy against prostate cancer is an alternative approach in overcoming hormonal/drug-resistant prostate cancer. Cytotoxic immune lymphocytes kill target cells via the perforin/gra...

Journal: :Journal of applied pharmaceutical sciences and research 2022

INTRODUCTION: Curcuminoids and Oleic acid, reported in the literature as antioxidant antitumor agents, were combined nanoemulsion, using Pluronic F127 a stabilizer.
 METHODS: The main objective is to investigate its cytotoxic activity against cancer cells.
 RESULTS AND DISCUSSION: nanoemulsion show values of particle size (251.4 ± 4.6 nm), zeta potential (-34.8 1.0 mV), pH (4.8) class...

Gholamreza Pourmand, Abbas Basiri, Mohammad Taghi Akbari, Seyedeh Maryam Seyedolmohadessin, Zahra Nourmohammadi,

Background: Prostate cancer is the second form of cancer among men worldwide. For early cancer detection, we should identify tumors in initial stages before the physical signs become visible. The present study aims to evaluate the diagnostic value of cell-free DNA (cfDNA), its comparison with prostate-specific antigen (PSA) level in prostate cancer screening and also in patients with localized ...

2016
Stephen O. Mathew Pankaj Chaudhary Sheila B. Powers Jamboor K. Vishwanatha Porunelloor A. Mathew

Prostate cancer is the most common type of cancer diagnosed and the second leading cause of cancer-related death in American men. Natural Killer (NK) cells are the first line of defense against cancer and infections. NK cell function is regulated by a delicate balance between signals received through activating and inhibitory receptors. Previously, we identified Lectin-like transcript-1 (LLT1/O...

Iraj Abedi, Masoud Rabbani, Mozafar Naserpour, Negar Abdi,

Background: Prostate cancer is the most common malignancy in men and the second leading cause of death in all countries of the world. The exact mechanism of prostate cancer is not known. On the other hand, early detection of prostate cancer can lead to a complete cure. Several clinical experiments including Digital Rectum Examination (DRE), biochemistry such as Prostate Specific Antigen (PSA), ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید